Nuvei: Canaccord Initiates Coverage With U$105 Price Target, Buy Rating

On Thursday, Canaccord Genuity became the 12th investment bank to initiate coverage on Nuvei Corporation (TSX: NVEI). Their analyst Joseph Vafi initiated coverage with a buy rating and U$105 price target. This puts Canaccord’s price target slightly below the street high of U$116 by Cowen and Company.

The mean 12-month price target sits at U$91.62, while the lowest comes in at U$74. Out of all 12 analysts, three have strong buy ratings, eight have buy ratings, and a single analyst has a hold rating.

Vafi says that when you zoom out and look at the greater payment space, Nuvei makes itself out to be a company that is specifically built for “better-than-average growth.” This comes in many forms, such as their unique payment platform or their “majority exposure to fast-growth e-commerce, impressive global footprint.” Nuvei has operations in North America, Europe, and Latin America. They say that due to Nuvei’s payment volume mainly coming from ecommerce, its peers should be PayPal and Adyen.

One of the best features Nuvei has, according to Vafi, is their “À la carte service,” in which they have a full suite of offerings, including FX, global payment in gaming, fraud, and crypto payments. These are all a way for Nuvei to build customers into their suite of offerings and help Nuvei have high customer retention and strong organic growth.

Vafi says, “we have been impressed with the Nuvei M&A strategy,” and believes due to its relatively smaller size, it can continue to target M&A opportunities in the payment sector that the larger players don’t even know about. They call Nuvei’s acquisition of SafeCharge, “a true game-changer for Nuvei.”

Canaccord believes that the first-quarter growth will continue into the rest of the year, with revenues increasing by 80% in the first quarter and 29% sequentially. Pro-forma revenue growth was up 44%, which makes Canaccord believe that they are gaining market share. They add, “we think Nuvei is well positioned to deliver outsized growth over the next couple of years.”

Below you can see Canaccord’s second quarter and full year estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Canada Should Be as Rich as Saudi Arabia. But It’s Not! | Michael Gentile

Artemis Gold Q3 Earnings: Growth Already In Focus

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

Recommended

Kalshi Faces Class Action Lawsuit Over Alleged Illegal Sports Betting

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Related News

Xebec Adsorption: Canaccord Gets Bullish On Company, Lifts Price Target

On April 12th, Xebec Adsorption (TSX: XBC) announced that it received a US$113.5 million order...

Saturday, April 16, 2022, 11:17:00 AM

PopReach Receives Upgraded Price Target from Canaccord Amid $5M Investment from Alibaba Investment Arm

On Thursday, PopReach (TSXV: POPR) announced a $5.0 million investment from eWTP Tech Innovation Fund...

Sunday, October 18, 2020, 12:48:00 PM

Canaccord: Meta Platforms’ Near Term Headwinds Are Priced In

On October 25th, Facebook (NASDAQ: FB), now called Meta Platforms, reported their 2021 third quarter...

Thursday, November 4, 2021, 05:08:00 PM

CloudMD: Canaccord Reiterates $3.25 Price Target Following Acquisition

This morning, CloudMD Software & Services (TSXV: DOC) announced that they purchased Rx Infinity, an...

Wednesday, January 27, 2021, 04:01:00 PM

Canaccord Raises CloudMD Price Target To $1.75 Following Financial Results

On Monday, CloudMD Software & Services (TSXV: DOC) reported its second-quarter financials. CloudMD’s revenue was...

Thursday, September 3, 2020, 02:37:00 PM